If you or a loved one has been diagnosed with Non-Hodgkin's Lymphoma or another form of lymphoma following extended use of Roundup® weed killer, you may be eligible to file a product liability claim against the manufacturer. Lawsuits filed across the country allege that the makers of Roundup failed to adequately warn users of serious cancer risks linked to glyphosate, the active ingredient in the product. Plaintiffs are pursuing justice for preventable harm caused by long-term exposure, and legal pathways remain open for new claimants.
Roundup is a glyphosate-based herbicide initially developed by Monsanto and now owned by Bayer AG. For decades, it has been used by:
Despite its widespread use, growing research has linked glyphosate exposure to an increased risk of Non-Hodgkin's Lymphoma (NHL) and other cancers. In 2015, the World Health Organization's International Agency for Research on Cancer (IARC) classified glyphosate as a "probable human carcinogen." Lawsuits allege that Monsanto was aware of these risks but failed to provide appropriate warnings, putting millions of users at risk.
Independent research has shown that frequent or prolonged exposure to glyphosate may increase the likelihood of developing cancers such as Non-Hodgkin's Lymphoma. Key findings include:
These findings support the core legal argument in current litigation: that exposure to Roundup may cause life-threatening conditions, and that users were not given the information necessary to make informed decisions about their health.
Roundup lawsuits are primarily centered around Non-Hodgkin's Lymphoma, but other related blood cancers may also be considered in legal claims. Potentially Eligible Diagnoses Include:
Eligibility may depend on the type of cancer, the duration and frequency of Roundup use, and the level of exposure over time.
You may be eligible to file a lawsuit if:
Claims can also be filed on behalf of deceased loved ones or as part of a wrongful death action. In many cases, the exposure may have occurred years before symptoms appeared, and you may still have time to take legal action.
Thousands of lawsuits nationwide have been filed alleging that:
These cases are currently being heard in both state and federal courts, including through consolidated multidistrict litigation (MDL) proceedings.
Filing a legal claim begins with a thorough review of your medical history, product exposure, and diagnosis. The process is confidential, and there is no obligation to move forward after your case is reviewed. Potential claimants should be prepared to provide:
Each case is evaluated individually, based on the strength of the evidence, timelines of exposure and diagnosis, and applicable laws in your state.
